Physiolysis for correction of clinodactyly with delta phalanx: Early improvement.

Cartilage de croissance Clinodactylie Clinodactyly Delta phalanx Growth plate Phalange delta Physiolyse Physiolysis Physis resection Résection physe

Journal

Hand surgery & rehabilitation
ISSN: 2468-1210
Titre abrégé: Hand Surg Rehabil
Pays: France
ID NLM: 101681801

Informations de publication

Date de publication:
04 2019
Historique:
received: 30 03 2018
revised: 02 12 2018
accepted: 07 12 2018
pubmed: 21 2 2019
medline: 12 2 2020
entrez: 21 2 2019
Statut: ppublish

Résumé

Congenital clinodactyly known as "delta phalanx" is a congenital finger deviation caused by a middle phalanx abnormality. Progressive realignment can be achieved with normal growth through physiolysis according to Vickers. The purpose of this investigation was to identify the rate of correction in congenital clinodactyly following epiphyseal bar resection.We studied retrospectively 24 fingers in 14 patients aged from 14 months to 11 years old (y/o), operated on by two surgeons performing epiphyseal bar resection using a modified Vickers' method. Angle measurements were compared pre-operatively, at 1 year and at the final follow-up. The rate of correction was evaluated at each time point. The cohort was divided into two groups: surgery < 6 y/o and ≥ 6 y/o. Statistical analyses were conducted to compare the patient groups.The mean deviation decreased from 33° pre-operatively (20°-80°) to 17.2° (0°-40°) at 1 year after surgery. The deviation at the last follow-up decreased to 10.6° (0°-40°). Seventy percent of the operated fingers were completely corrected (angle ≤ 10°) at the latest follow-up visit. No difference was found regarding the age at surgery. There were two cases of premature fusion of the epiphyseal plates. Regardless of the patient's age, Vickers' procedure is a simple and effective solution for treating delta phalanx with early correction. Our data suggest that physiolysis is a successful surgery in patients up to 11 years old. LEVEL OF EVIDENCE: Level IV, therapeutic case series.

Identifiants

pubmed: 30782503
pii: S2468-1229(18)30439-0
doi: 10.1016/j.hansur.2018.12.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-128

Informations de copyright

Copyright © 2019 SFCM. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

L El Sayed (L)

Hospital Necker-Enfants Malades, 149, rue de Sèvres, Paris 75015, France. Electronic address: Lailaelsayed@msn.com.

A Salon (A)

Hospital Necker-Enfants Malades, 149, rue de Sèvres, Paris 75015, France.

C Glorion (C)

Hospital Necker-Enfants Malades, 149, rue de Sèvres, Paris 75015, France.

S Guero (S)

Hospital Necker-Enfants Malades, 149, rue de Sèvres, Paris 75015, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH